Literature DB >> 948215

Tissue levels of clofazimine in a case of leprosy.

K V Desikan, S Balakrishnan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 948215     DOI： 10.5935/0305-7518.19760020

Source DB:  PubMed          Journal:  Lepr Rev        ISSN： 0305-7518            Impact factor:   0.537


× No keyword cloud information.
  6 in total

1.  Tetramethylpiperidine-substituted phenazines inhibit the proliferation of intrinsically multidrug resistant carcinoma cell lines.

Authors:  E van Niekerk; J F O'Sullivan; G K Jooné; C E van Rensburg
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

2.  Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation.

Authors:  Yu Lu; Meiqin Zheng; Bin Wang; Lei Fu; Weijie Zhao; Peng Li; Jian Xu; Hui Zhu; Haixia Jin; Dali Yin; Haihong Huang; Anna M Upton; Zhenkun Ma
Journal:  Antimicrob Agents Chemother       Date:  2011-08-15       Impact factor: 5.191

3.  Characterization of Clofazimine as a Potential Substrate of Drug Transporter.

Authors:  M Rasheduzzaman Jony; Yong-Soon Cho; Nguyen Phuoc Long; Ho-Jung Shin; Jae-Gook Shin
Journal:  Antimicrob Agents Chemother       Date:  2022-03-07       Impact factor: 5.938

Review 4.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

5.  Antimicrobial activities of clofazimine and B669 are mediated by lysophospholipids.

Authors:  C E Van Rensburg; G K Jooné; J F O'Sullivan; R Anderson
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

Review 6.  Clinical pharmacokinetics of clofazimine. A review.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.